Pharma Bio – Diabetes API US, Modular Construction
Scope: Construct new pharmaceutical manufacturing facility for the production of next generation diabetes drug and applicator for confidential client.
Budget: $1.83 B
Schedule: 2016 – Present
Highlights: Develop and maintain a Supplier Supervision Program (SSP) monitor and enforce schedule, cost, quality and constructability compliance for a large multi-vendor offsite fabrication program.
Mitigations/Successes: Expedited schedule by 3 months by identifying critical activities early that can be mitigated before it impacts fabrication schedule. Minimized risk associated with the installation of various engineered equipment by developing shipping priorities and developing installation scopes with various vendors.